CAS# 170851-70-4
Also Known As NNC 26-0161
Class Synthetic Pentapeptide / GHSR Agonist
Form Lyophilized Powder
Receptor Target
Peptide Length
Molecular Weight
Ipamorelin (NNC 26-0161, CAS# 170851-70-4) is a synthetic pentapeptide classified as a selective growth hormone secretagogue receptor (GHSR) agonist. Comprising five amino acids, it is among the most selective GHSR agonists studied in preclinical research, with a defined binding profile at GHSR-1a that is studied for its selectivity relative to other secretagogue peptides. Supplied by NexPept as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.
Molecular Profile
CAS#, sequence, molecular weight, analytical data
CAS#, sequence, molecular weight, analytical data
| Property | Value |
|---|---|
| CAS Number | 170851-70-4 |
| Research Designation | NNC 26-0161 |
| Compound Class | Synthetic pentapeptide — selective GHSR-1a agonist |
| Sequence Length | 5 amino acids |
| Molecular Weight | 711.86 Da |
| Receptor Target | GHSR-1a (Growth Hormone Secretagogue Receptor type 1a) |
| Selectivity Profile | Selective — does not significantly bind cortisol or prolactin pathways in vitro |
| Physical Form | Lyophilized powder |
| Analytical Method | High-Performance Liquid Chromatography (HPLC) + Mass Spectrometry (MS) |
| Appearance | White to off-white lyophilized solid |
In Vitro Research Context
Receptor pharmacology — laboratory use only
Receptor pharmacology — laboratory use only
A G protein-coupled receptor (GPCR) involved in endocrine signalling regulation. Ipamorelin is studied for its selective agonist activity at GHSR-1a in receptor binding assays, selectivity profiling studies, and endocrine signalling pathway models. Its selectivity relative to other GHSR-targeting peptides makes it a useful comparator compound in structure–function research.
Ipamorelin is studied in preclinical in vitro settings as a selective pharmacological tool for investigating GHSR-1a receptor binding and downstream signalling. Its defined selectivity profile — distinct from broader-acting secretagogue peptides — makes it particularly relevant for comparative receptor pharmacology studies and for isolating GHSR-1a-specific signalling cascades in controlled laboratory models.
Research context: Ipamorelin is an investigational synthetic pentapeptide studied in scientific research involving GHSR-1a signalling and endocrine pathway models. It has not been authorized by Health Canada for human or veterinary use.
Available Formats
10mg — lyophilized powder
10mg — lyophilized powder
| Format | Net Quantity | Physical Form |
|---|---|---|
| Ipamorelin 10mg | 10 mg / vial | Lyophilized powder |
Sourced from a verified batch. Quantity for use should be determined based on your specific in vitro research protocol by qualified research personnel.
Laboratory Storage
Controlled storage conditions for lyophilized material
Controlled storage conditions for lyophilized material
Store sealed lyophilized material under controlled laboratory conditions in accordance with validated institutional SOPs and applicable technical documentation. Protect from light and moisture. Handling conditions should be established by qualified research personnel in accordance with the specific experimental protocol.
Note: No preparation, reconstitution, or administration instructions are provided. This compound is supplied for in vitro laboratory research use only. All handling must be conducted by qualified personnel following institutional safety protocols.
Research Literature
Scientific references & related resources
Scientific references & related resources
Ipamorelin Research Peptide Overview — NexPept compound overview and in vitro research context
PubMed — Ipamorelin / NNC 26-0161 — peer-reviewed scientific literature on this compound
Research Peptides in Canada — sourcing and research context for Canadian laboratories
What Are Research Peptides? — peptide classification and in vitro research context
This product is supplied exclusively for in vitro laboratory and non-clinical research use by qualified research personnel. It is not authorized by Health Canada for human or veterinary use. No therapeutic, clinical, or health claims are made.
This material must not be administered to humans or animals. No dosage, preparation, reconstitution, or administration instructions are provided or implied. All handling and use must be conducted by qualified personnel in accordance with applicable institutional policies and legal requirements.
Be the first to review “Ipamorelin 10mg”
Related products
Nootropic & Wellness Research
Reviews
There are no reviews yet.